Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-fentanyl target-controlled infusion versus desflurane in cirrhotic patients undergoing major hepatic resection
PACTR201402000759256Completed
- Sponsor
- Amr el safty
- Start
- Feb 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propofol, fentanyl and desflurane in hepatocellular carcinoma (HCC) and Cirrhosis (2 arms), sponsored by Amr el safty. Primary endpoint: Hepatocellular integrity. Started Feb 2012; status: completed.
02
Drugs
propofolfentanyldesflurane
03
Conditions
hepatocellular carcinoma (HCC)Cirrhosis
Beyond the preview
Go deeper on PACTR201402000759256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201402000759256.